Lanzatech co-founder: we are missing out on the synthetic biology revolution

Lanzatech co-founder: we are missing out on the synthetic biology revolution
Dr Sean Simpson. (Image: Getty)
Peter Griffin
The third New Zealand-founded company in as many years is set to list on the Nasdaq.LanzaTech’s merger with “blank cheque” Nasdaq-listed company AMCI Acquisition Corp II sees it follow in the footsteps of Rocket Lab and footwear maker All Birds in taking the special purpose acquisition company (SPAC) route to become a publicly traded company.The deal, which values the merged company at around US$1.8 billion (NZ$2.8b), was cleared by shareholders on Tuesday. It confirms the Illinois-based LanzaTech’s status as our mo...

More Opinion

The value of financial advice
Opinion

David Chaplin: The value of financial advice

Countries that banned product commissions have backtracked a little in recent years.

When the Hopium wears off
Opinion

Dileepa Fonseka: When the Hopium wears off

Whatever happened to all those green shoots?

Dileepa Fonseka 13 Oct 2025